Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Tauklarify (florquinitau f-18)FDA approves Tauklarify (florquinitau f-18)13 August 2026The FDA approved Tauklarify (florquinitau f-18), a drug from Cerveau Lantheus. Form: Solution, Intravenous. Application NDA220496.FDA New Drug Approvals calendarMore from this calendar

20 October 2026 - FDA approves Hibsago (bepirovirsen)

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))